MedPath

A study to see changes after antiVEFG injection ranibizumab in Retinal Vein Occlusion using OCT Angiography patients at SMS hospital

Phase 2
Conditions
Health Condition 1: H00-H59- Diseases of the eye and adnexa
Registration Number
CTRI/2023/08/056558
Lead Sponsor
SMS Medical College and Hospital Jaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Recent episode of RVO

Presence of Macular Edema

Minimum 3 months of follow up

Well informed written consent

Exclusion Criteria

Uncooperative patients

Big media opacity

Ocular infection

Ocular trauma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath